跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRIAXONE INJECTION 2 G/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
TRIAXONE INJECTION 2 G/VIAL
Approved
THERAPEUTIC
TRIAXONE INJECTION 2 G/VIAL
HANMI PHARM CO LTD (KOREA, REPUBLIC OF)
🇸🇬 Health Sciences Authority
Approval Date
Nov 30, 2002
Approval ID
daf285d3deaf7dca
Company
HANMI PHARM CO LTD (KOREA, REPUBLIC OF)
Type
Therapeutic
Approval Details
Approval Id
daf285d3deaf7dca
Drug Name
TRIAXONE INJECTION 2 G/VIAL
Product Name
TRIAXONE INJECTION 2 G/VIAL
Approval Number
SIN12134P
Approval Date
2002-11-30
Registrant
SHOEI UNIVERSAL CORPORATION PTE LTD
Licence Holder
SHOEI UNIVERSAL CORPORATION PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
J01DD04
Atc Item Name
ceftriaxone
Pharma Manufacturer Name
SHOEI UNIVERSAL CORPORATION PTE LTD
Company Detail Path
/organization/shoei-universal-corporation-pte-ltd
Active Ingredients
CEFTRIAXONE SODIUM 2.37 g/vial EQV CEFTRIAXONE
2 g/vial
CEFTRIAXONE SODIUM 2.37 G/VIAL EQV CEFTRIAXONE
2 G/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 30, 2002
Approval ID
daf285d3deaf7dca
Type
Therapeutic
Back to HSA Approvals